EGFR and astrocytic tumor: Rare combinations of histology and molecular features including oligodendroma, histologically noted glioblastoma tumors with unknown IDH1/2 status, or IDH-WT high-grade astrocytic tumors with wild-type EGFR or TERT promoter mutations were excluded from the analysis (Figure 1).